Phase I-II trial of VACOP-B plus filgrastim (G-CSF) support for HIV-related non-Hodgkins lymphoma (NHL).
Conferences
-
- Overview
-
- Research
-
- Additional Document Info
-
- View All
-
Overview
status
publication date
has subject area
published in
Research
keywords
-
Hematology
-
Life Sciences & Biomedicine
-
Science & Technology
Additional Document Info
start page
end page
volume
issue